Загрузка...
An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
INTRODUCTION: Hyporesponsiveness to recombinant human erythropoietin (rhEPO) is a major problem affecting some patients with chronic kidney disease (CKD), predominantly those on hemodialysis (HD). Daprodustat (GSK1278863) is a hypoxia-inducible factor prolyl hydroxylase inhibitor that is being inves...
Сохранить в:
| Опубликовано в: : | Kidney Int Rep |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6035126/ https://ncbi.nlm.nih.gov/pubmed/29989040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.02.009 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|